SCHEMBL3945103

SCHEMBL3945103

O=C(O)C1(c2ccc(-c3ccc(OC(F)(F)F)cc3)c(F)c2)CC1.O=C(O)C1(c2ccc(-c3cccc(C(F)(F)F)c3)c(F)c2)CC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.80
AKR1C2 P52895 7/20 0.80
APP P05067 10/20 0.67
AKR1C1 Q04828 3/20 0.64
CYP2C9 P11712 7/20 0.57
CYP2C19 P33261 6/20 0.57
CYP3A4 P08684 6/20 0.57
CYP2D6 P10635 3/20 0.55
AKR1B10 O60218 1/20 0.53
AKR1C4 P17516 1/20 0.53
PSEN1 P49768 1/20 0.53
PSEN2 P49810 1/20 0.53
APH1B Q8WW43 1/20 0.53
NCSTN Q92542 1/20 0.53
APH1A Q96BI3 1/20 0.53
PSENEN Q9NZ42 1/20 0.53
CYP1A2 P05177 1/20 0.52
LPAR1 Q92633 1/20 0.41
LPAR3 Q9UBY5 1/20 0.41
SERPINE1 P05121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374499 0.89 APP (0.71) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL1373508 0.89 AKR1C3 (1.00) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL1373495 0.86 AKR1C3 (0.69) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL1373506 0.81 APP (1.00) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL411735 0.78 APP (0.76) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL3945107 0.77 AKR1C3 (0.46) AKR1C3AKR1C2APPSERPINE1
SCHEMBL5791300 0.77 AKR1C3 (0.70) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL5790831 0.76 AKR1C3 (0.49) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL5448540 0.74 APP (1.00) AKR1C3AKR1C2APPAKR1C1CYP2C9
SCHEMBL1465617 0.73 KMT2A (0.48) AKR1C3AKR1C2APPAKR1C1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046119-A2 TREATMENT OF PSYCHIATRIC DISORDERS Myriad Genetics, Inc. (US) 2009-04-15 EP claimed
WO-2008006099-A2 TREATMENT OF PSYCHIATRIC DISORDERS MYRIAD GENETICS, INC. (US) 2008-01-10 WO claimed
WO-2006020853-A2 PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS MYRIAD GENETICS, INC. (US) 2006-02-23 WO disclosed